[1]AGGAR WALC.DNA based immune otherapy for HPV associated head and neck cancer[J].Immunotherapy,2016,8(10):1187-1192.
[2]LPINE C,VORON T,BERREBI D,et al.Juvenile-onset recurrent respiratory papillomatosis aggressiveness:in situ study of the level of transcription of HPV E6 and E7[J].Cancers(Basel),2020,12(10):E2836.
[3]阿依恒·曲库尔汗,尼力帕尔·阿力木,皮力东·库亚西,等.小儿复发性呼吸道乳头状瘤病所致喉阻塞外科治疗特点分析[J].中国小儿血液与肿瘤杂志,2011,16(02):86-88,92.
AYIHENG·QKEH,NILIPAER·ALM,PILIDONG·KYX,et al.Feature analysis of surgical treatment of recurrent respiratory papillomatosis with laryngeal obstruction in children[J].Chinese Journal of Pediatric Hematology and Oncology,2011,16(02):86-88,92.
[4]LIAO Y,CAO W,ZHANG K,et al.Bioinformatic and integrated analysis identifies an lncRNA-miRNA-mRNA interaction mechanism in gastric adenocarcinoma[J].Genes Genomics,2021,43(6):613-622.
[5]CHAN JJ,TAY Y.Noncoding RNA:RNA regulatory networks in cancer[J].Int J Mol Sci,2018,19(5):1310.
[6]WANG Y,WANG Y,LUO W,et al.Roles of long non-coding RNAs and emerging RNA-binding proteins in innate antiviral responses[J].Theranostics,2020,10(20):9407-9424.
[7]CHEN G,SHI TL,SHI LM.Characterizing and annotating the genome using RNA-seq data[J].Science China(Life Sciences),2017,60(02):116-125.
[8]齐雯雯,陈鲁秋,贾涛,等.复发性喉乳头状瘤中潜在生物学标志物的筛选及生物信息学分析[J].山东大学耳鼻喉眼学报,2021,35(05):75-84.
QI WW,CHEN LQ,JIA T,et al.Potential biomarkers and bioinformatics analysis of differentially expressed genes in recurrent laryngeal papilloma[J].Journal of Otolaryngology and Ophthalmology of Shandong University,2021,35(05):75-84.
[9]LIU J,YANG T,ZHANG Y,et al.Promotion of BZW2 by LINC00174 through miR-4500 inhibition enhances proliferation and apoptosis evasion in laryngeal papilloma[J].Cancer Cell Int,2020,20:471.
[10]ZHAO D,HOU Y.Long non-coding RNA nuclear-enriched abundant transcript 1(LncRNA NEAT1) upregulates Cyclin T2 (CCNT2) in laryngeal papilloma through sponging miR-577/miR-1224-5p and blocking cell apoptosis[J].Bioengineered,2022,13(1):1828-1837.
[11]CHEN J,WANG Y,ZHANG X,et al.H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer[J].Neoplasma,2016,63(2):223-230.
[12]CHEN MJ,DENG J,CHEN C,et al.LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis[J].Int J Biochem Cell Biol,2019,113(5):27-36.
[13]韩树坤,彭雪强,韩冰.过表达长链非编码RNA H19对肝癌细胞增殖和自噬的影响及可能机制[J].现代肿瘤医学,2020,28(16):2754-2758.
HAN SK,PENG XQ,HAN B.Effect and mechanism of long noncoding RNA H19 overexpression on proliferation and autophagy in HCC cells[J].Modern Oncology,2020,28(16):2754-2758.
[14]LAN X,SUN W,DONG W,et al.Downregulation of long noncoding RNA H19 contributes to the proliferation and migration of papillary thyroid carcinoma[J].Gene,2018,646:98-105.
[15]陈函,罗晓勇,李朝萍,等.lncRNA CASC2对结直肠癌细胞功能及血管生成的影响[J].实用肿瘤学杂志,2022,36(02):111-118.
CHEN H,LUO XY,LI CP,et al.The effect of lncRNA CASC2 on the function and angiogenesis of colorectal cancer cells[J].Practical Oncology Journal,2022,36(02):111-118.
[16]ZHANG Y,QIAN W,FENG F,et al.Upregulated lncRNA CASC2 may inhibit malignant melanoma development through regulating miR-18a-5p/RUNX1[J].Oncol Res,2019,27(3):371-377.
[17]HE X,LIU Z,SU J,et al.Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer[J].Tumour Biol,2016,37:9503-9510.
[18]LI P,XUE WJ,FENG Y,et al.Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway[J].Am J Transl Res,2016,8:3522-3529.
[19]LIU CH,ZHANG Y,SHE X,et al.A cytoplasmic long noncoding RNA LINC00470 as a new AKT activator to mediate glioblastoma cell autophagy[J].J Hematol Oncol,2018,11(1):77.
[20]LIU CH,FU HJ,LIU XP,et al.LINC00470 coordinates the epigenetic regulation of ELFN2 to distract GBM cell autophagy[J].Mol Ther,2018,26(9):2267-2281.
[21]HUANG T,WANG YJ,HUANG MT,et al.LINC00470 accelerates the proliferation and metastasis of melanoma through promoting APEX1 expression[J].Cell Death Dis,2021,12(5):410.
[22]WANG R,MA Z,FENG L,et al.LncRNA MIR31HG targets HIF1A and P21 to facilitate head and neck cancer cell proliferation and tumorigenesis by promoting cell-cycle progression[J].Mol Cancer,2018,17(1):162.
[23]曹晓智,刘银华,韩艳丽,等.lncRNA MIR31HG在甲状腺乳头状癌组织中表达及其临床意义[J].中华实用诊断与治疗杂志,2021,35(10):1017-1020.
CAO XZ,LIU YH,HAN YL,et al.Expression of lncRNA MIR31HG in papillary thyroid carcinoma and its clinical significance[J].Journal of Chinese Practical Diagnosis and Therapy,2021,35(10):1017-1020.
[24]YANG H,LIU P,ZHANG J,et al.Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b[J].Oncogene,2016,35:3647-3657.
[25]CHENG S,ZHANG X,HUANG N,et al.Down-regulation of S100A9 inhibits osteosarcoma cell growth through inactivating MAPK and NF-KB signaling pathways[J].Bme Cancer,2016,16(1):1-12.
[26]李险波,张志强,韩小勇,等.LIMD2基因表达对食管癌细胞增殖、凋亡及ERK/MAPK信号通路的影响[J].局解手术学杂志,2022,31(08):669-675.
LI XB,ZHANG ZQ,HAN XY,et al.Effects of LIMD2 gene expression on the proliferation,apoptosis and ERK/MAPK signal pathway of esophageal cancer cells[J].Journal of Regional Anatomy and Operative Surgery,2022,31(08):669-675.
[27]王凡,蒋海静,李成林.黄酮类新化合物LFG-500通过调控MAPK和AKT/mTOR信号通路抑制人乳腺癌MCF-7细胞增殖[J].中国处方药,2022,20(09):42-44.
WANG F,JIANG HJ,LI CL,et al.LFG-500,a novel synthetic flavonoid,inhibits the proliferation of human breast cancer cell MCF-7 by regulating MAPK and AKT/mTOR signaling pathway[J].Journal of China Prescription Drug,2022,20(09):42-44.
[28]MA XL,SHANG F,NI W,et al.Correction to:MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1[J].J Cancer Res Clin Oncol,2022,148(3):749-750.
[29]王秀芝,王国强,路以荣,等.FAM198B通过激活PI3K-AKT信号通路促进胃癌细胞的恶性增殖及转移[J].胃肠病学和肝病学杂志,2020,29(06):671-676.
WANG XZ,WANG GQ,LU YR,et al.FAM198B promotes the malignant proliferation and metastasis of gastric cancer cells by activating the PI3K-AKT signaling pathway[J].Chinese Journal of Gastroenterology and Hepatology,2020,29(06):671-676.